In trials immediately before the block change, the mean of the action value for the optimal choice became high.
We introduced choice biases to the monkeys' decision process (value component) by randomly interleaving balanced reward conditions (equal reward value for the two choices) with unbalanced conditions (one alternative worth twice as much as the other).
Around one-third of respondents agreed that a PBS listing for a medicine meant that it had been assessed as cost-effective (a "value-for-money" choice).
The interviewer used a change board with the ping-pong approach varying the probability p in steps of 0.05 to find the value p where the respondent considered choice A = choice B. This value of p is the utility value for the health state in choice A in the interval from dead (0) to full health (1).
Since in practice we do not know how similar the growth rates are, these results suggest running the analysis both with and without prior knowledge and looking at the evidence value for the most appropriate prior choice in each case.
Although any choice of a peeling sequence will lead to the same value for the likelihood, not all choices of the peeling sequence lead to anterior cutsets of the same size.
As a consequence, the choice of value for the smooth parameter, S, should be set as to maximize the recognition of an objective quantity, such as information content.
Interviewers used a chance board with a ping-pong approach varying the probability p in steps of 0.05 to obtain the value, p*, where the patient considered choice A equal to choice B. This indifference probability, p*, is the utility value for the patient's own health in choice A in the interval from dead (= 0) to full health (= 1).
Listing the parameters and their chosen values, along with the rationale for the choice, is a key task.
And, not least, how can they make informed, value-for-money choices?
